Fiore Cannabis Announces Virtual AGM Details
April 14, 2021
Ryan Allway April 14th, 2021 News, Top News Kelowna, British Columbia–(Newsfile Corp. – April 14, 2021) – Fiore Cannabis Ltd. (CSE: FIOR) (OTCQX: FIORF) (“Fiore” or the “Company”), a licensed multi-state cannabis cultivator, producer and retailer, today announced details for its upcoming virtual Annual General Meeting (the “AGM”) to... Read more
Ryan Allway April 13th, 2021 News, Top News Kelowna, British Columbia–(Newsfile Corp. – April 13, 2021) – Fiore Cannabis Ltd. (CSE: FIOR) (OTCQX: FIORF) (“Fiore” or the “Company”), a licensed multi-state cannabis cultivator, producer and retailer, today announced preliminary revenue results for the first quarter ended March 31, 2021... Read more
Psychedelic Wellness-Focused Company Delic Holdings Provides First Quarter 2021 Shareholder Update
April 12, 2021
Ryan Allway April 12th, 2021 Psychedelics, Top News VANCOUVER, BC, April 12, 2021 /PRNewswire/ – Delic Holdings Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to provide the following shareholder update on its operations for the first quarter of 2021. The first quarter of 2021... Read more
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx(TM)
April 12, 2021
Ryan Allway April 12th, 2021 News, Top News Results expected to support the Company’s plans to file an IND application with the FDA for a Phase II international trial in acute myocarditis Oakville, Ontario–(Newsfile Corp. – April 12, 2021) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) (“Cardiol” or the “Company”), a clinical-stage biotechnology... Read more
Ryan Allway April 9th, 2021 App, Exclusive, Psychedelics, Top News The psychedelics sector is quickly evolving into a multi-billion-dollar industry with a growing number of publicly traded companies. As with any new industry, there are many companies backed by little more than financiers looking to make a quick dollar... Read more
Gage Cannabis Announces Exclusive Partnership With Blue River™ to Bring Award-Winning Cannabis Extracts to Michigan
April 8, 2021
Pursuant to the partnership and pending regulatory approval, Gage has been granted a license to produce and distribute Blue River™ branded products. Blue River™ products sold in Michigan will be manufactured with Gage’s premium flower. Subject to the receipt of applicable regulatory approvals, Blue River™’s brands are expected to be available... Read more
Silo Pharma Finalizes Sublicense Deal for its Targeted Psilocybin Cancer Therapeutic Technology
April 7, 2021
Ryan Allway April 7th, 2021 Psychedelics, Top News Agreement to explore the use of Silo Pharma’s Novel Peptide Englewood Cliffs, NJ, April 07, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that... Read more
Ryan Allway April 5th, 2021 App, Exclusive, Top News Many early cannabis companies were forced into vertical-integration due to regulatory constraints. While it may make sense for cultivators to create extracts, it doesn’t always make sense for them to own commercial kitchens for confections or bottling machines for beverages,... Read more
Ryan Allway April 2nd, 2021 News, Top News NEW YORK, April 02, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Potbotics, Inc. o/a RYAH (“RYAH” or the “Company“) is pleased to announce that, in connection with its previously announced business combination (the “Transaction”) with Prime Blockchain, Inc. (“Prime”), the resulting issuer that will be... Read more
European Pharmaceutical Company STADA and MediPharm Labs Begin First Sales in Germany Under Exclusive Agreement
April 1, 2021
BARRIE, Ontario, April 1, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced STADA Arzneimittel AG (STADA), a leading European consumer health and generics company, and MediPharm Labs, under an exclusive, turnkey... Read more
